Lan Yang

2.1k citations
60 papers · 1.7k · 1 hit paper · h-index 21

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Genetics top 10%
    • Estrogen and related hormone effects

Papers in

Lan Yang

56 papers receiving 1.7k citations

Lan Yang's Hit Papers

Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression 2019 · 342 citations
3420+2+4Years since publication100200300

Peers

Lan Yang
Comparison fields: 5 of 94
  • Cancer Research 264
  • Genetics 296
  • Molecular Biology 601
  • Oncology 177
  • Immunology and Allergy 34
Replace Brian M. Necela with:
Brian M. Necela United States
Helene Solberg Denmark
Yun‐Ru Liu Taiwan
Viqar Syed United States
Jayashree Karar United States
Wei Xiong China
Nam‐ho Huh Japan
Juan Carlos Rodrı́guez-Manzaneque Spain
Chengshi Quan China
Simonetta Astigiano Italy
Lan Yang relative to Brian M. Necela United States Brian M. Necela's profile →
Citations per field
00.5×1.5×
Brian M. Necela · 1×
Citations per year

Countries citing papers authored by Lan Yang

Since Specialization
Citations

This map shows the geographic impact of Lan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Yang more than expected).

Fields of papers citing papers by Lan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Yang. The network helps show where Lan Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lan Yang Line = papers co-authored together Lan Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression
Hit paper breakdown →
2019342
2 1999263
3 2000115
4 199973
5 201570
6 201566
7 201758
8 201956
9 201752
10 201952
11 201342
12 201035
13 201532
14 201329
15 200424
16 200924
17 201722
18 201421
19 201521
20 201921

About Lan Yang

Lan Yang is a scholar working on Cancer Research, Immunology, Molecular Biology, Genetics and Surgery, having authored 60 papers that have together received 1.7k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (8 papers), MicroRNA in disease regulation (7 papers), Epigenetics and DNA Methylation (4 papers), Estrogen and related hormone effects (4 papers), Cervical Cancer and HPV Research (3 papers), Immune cells in cancer (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Cancer Research (264 citations), Genetics (296 citations), Molecular Biology (601 citations), Oncology (177 citations) and Immunology and Allergy (34 citations). Lan Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Michael R. Stallcup, Heng Hong, Jianming Hu, Xiaobin Cui, Yunzhao Chen, Donald Benedict DeFranco, Hao Peng, Hong Zhou, Dandan Wang and Xueping Han. Their work appears in journals such as International Immunopharmacology, Advances in experimental medicine and biology, Journal of Biological Chemistry, Epigenetics and Journal of Experimental & Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact